Cargando…
CD33 Expression on Peripheral Blood Monocytes Predicts Efficacy of Anti-PD-1 Immunotherapy Against Non-Small Cell Lung Cancer
Non-small cell lung carcinoma (NSCLC) is the leading cause of cancer-related deaths globally. Immune checkpoint blockade (ICB) has transformed cancer medicine, with anti-programmed cell death protein 1 (anti-PD-1) therapy now well-utilized for treating NSCLC. Still, not all patients with NSCLC respo...
Autores principales: | Olingy, Claire, Alimadadi, Ahmad, Araujo, Daniel J., Barry, David, Gutierrez, Norma A., Werbin, Max Hardy, Arriola, Edurne, Patel, Sandip Pravin, Ottensmeier, Christian H., Dinh, Huy Q., Hedrick, Catherine C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046782/ https://www.ncbi.nlm.nih.gov/pubmed/35493454 http://dx.doi.org/10.3389/fimmu.2022.842653 |
Ejemplares similares
-
Monocyte heterogeneity and functions in cancer
por: Olingy, Claire E., et al.
Publicado: (2019) -
Nonclassical monocytes potentiate anti-tumoral CD8(+) T cell responses in the lungs
por: Padgett, Lindsey E., et al.
Publicado: (2023) -
MET Inhibitors in Small Cell Lung Cancer: From the Bench to the Bedside
por: Hardy-Werbin, Max, et al.
Publicado: (2019) -
Human CD79b(+) neutrophils in the blood are associated with early-stage melanoma
por: Meyer, Melissa A., et al.
Publicado: (2023) -
Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic
por: Rios-Hoyo, Alejandro, et al.
Publicado: (2023)